Aquinox Pharmaceuticals (AQXP) Priced

Early-stage biotech developing treatments for inflammation of the lung and bladder.

Health Care - Biotechnology

IPO Performance
Latest Trade $18.29 0.00 (0.0%)
First Day Return 8.6%
Return from IPO 66.3%
 
Aquinox Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 01/28/2014
Offer Price $11.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.2
Deal Size ($mm) 46
 
IPO Data
IPO Date 03/06/2014
Offer Price $11.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.2
Deal Size ($mm) $46
 
Underwriters
more
Business Overview
Early-stage biotech developing treatments for inflammation of the lung and bladder.
Early-stage biotech developing treatments for inflammation of the lung and bladder.
more
Company Data
Headquarters Vancouver, , Canada
Founded 2003
Employees 12
Website www.aqxpharma.com
 

Performance vs. IPO Index (IPOUSA)